Document:

NEXCORE HEALTHCARE CAPITAL CORP

RESTRICTED SECURITIES
AWARD AGREEMENT

This Restricted
Securities Award Agreement (the “Agreement”) is made as of December 16, 2013 (the “Grant
Date”) by and between NexCore Healthcare Capital Corp, a Delaware corporation (the “Company”),
and Gregory C. Venn (the “Grantee”).

In consideration
of the mutual covenants and representations set forth below, the Company and the Grantee agree as follows:

1.                 
Grant of the Restricted Securities. Subject to the terms and conditions of this Agreement,
the Company hereby awards to the Grantee 174,675 shares of common stock of the Company and 174,675 Class B Units of NexCore Real
Estate LLC (the “Shares”). The Shares, whether vested or unvested, shall be subject to the terms of the
Company’s Voting Agreement and Lock-up Agreement, if applicable. 

2.                 
Forfeiture.

A.                
Forfeiture of Unvested Shares Upon Cessation. In the event that the Grantee
ceases to be an employee of the Company (a “Service Provider”), any Shares which have not yet vested
pursuant to Section 3 below (the “Unvested Shares”) shall be immediately and automatically forfeited
without consideration; provided, however, such Shares shall not be forfeited but shall immediately vest in accordance with Section
3 upon Grantee’s cessation of employment with the Company due to (i) a termination without Cause, (ii) Grantee’s death,
Disability or Retirement, or (iii) a Change of Control.

B.the
termination of the Grantee’s employment by act of the Company’s board of directors on account of (i) an act
by the Grantee of willful misconduct, willful or gross neglect, fraud, misappropriation or embezzlement in the performance of the
Grantee’s duties with the Company; (ii) repeated failure to adhere to the lawful directions of Company management, or
to adhere to the Company’s lawful policies and practices; (iii) continued failure to substantially perform the Grantee’s
duties properly assigned to him after demand for substantial performance is delivered by the Company specifically identifying the
manner in which the Company believes the Grantee has not substantially performed his duties

C.“Disability”
Definition. For purposes of this Agreement, “Disability” means a permanent and total disability
(within the meaning of Section 22(e) of the Internal Revenue Code of 1986), as determined by a medical doctor satisfactory to the
board of directors of the Company.

D.“Retirement” Definition.
For purposes of this Agreement, “Retirement” means the voluntary termination of employment or engagement by
an employee or consultant of the Company or an affiliate who represents that he/she is not performing and does not intend to perform
any activities similar to the Company’s business activities, whether or not in competition with the Company.

E.“Change
of Control” Definition. For purposes of this Agreement, a “Change of Control” means
either: 

    	1

    	 

    

 

(1)              
the acquisition of the Company by another entity by means of any transaction or series of
related transactions (including, without limitation, any reorganization, merger or consolidation or securities transfer, but excluding
any such transaction effected primarily for the purpose of changing the domicile of the Company), unless the Company’s shareholders
or members immediately prior to such transaction or series of related transactions hold, immediately after such transaction or
series of related transactions, at least 50% of the voting power of the surviving or acquiring entity (provided that the
sale by the Company of its securities for the purposes of raising additional funds shall not constitute a Change of Control hereunder);
or

(2)              
a sale of all or substantially all of the assets of the Company; or

(3)              
the complete liquidation or dissolution of the Company. 

3.                 
Vesting.

A.                
Vesting. One-third (1⁄3) of the total number of Shares shall vest
immediately on the Grant Date. So long as the Grantee’s continuous status as a Service Provider has not yet terminated, then
one-third (1⁄3) of the total number of Shares shall vest on the first anniversary of the Grant Date, and the remaining one-third
(1⁄3) of the total number of the Shares shall vest on the second anniversary of the Grant Date. As Shares vest, such Shares
shall be referred to as the “Vested Shares.” 

B.                
Acceleration upon a Change of Control. Upon a Change of Control, all of the
Unvested Shares shall immediately become Vested Shares. 

C.                
 Acceleration upon a Termination without Cause. In the event Grantee’s
employment with the Company is terminated without Cause, all of the Unvested Shares shall immediately become Vested Shares.

D.                
Acceleration upon Grantee’s Death, Disability or Voluntary Retirement.
In the event of Grantee’s death, Disability or voluntary retirement from the Company, all of the Unvested Shares shall immediately
become Vested Shares.

E.                 
Restrictions on Securities Distributed In Kind. Any securities that may be distributed
in kind to Grantee by the Company after the date hereof, shall be subject to the same restrictions as the Shares to which they
relate are subject to pursuant to this Agreement, including all vesting and forfeiture provisions herein. 

4.                 
Limitation on Payments.

A.                
Payments Limitation. In the event that the severance and other benefits
provided for in this Agreement or otherwise payable to the Grantee (i) constitute “parachute payments” within
the meaning of Section 280G of the Code, and (ii) would be subject to the excise tax imposed by Section 4999 of
the Code (the “Excise Tax”), then the Grantee’s benefits under this Agreement shall be either:

(1)              
delivered in full, or

    	2

    	 

    

 

 

(2)              
delivered as to such lesser extent which would result in no portion of such benefits being
subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income
taxes and the Excise Tax, results in the receipt by the Grantee on an after-tax basis, of the greatest amount of benefits, notwithstanding
that all or some portion of such benefits may be taxable under Section 4999 of the Code. Any reduction in payments and/or
benefits required by this Section 4 will occur in the following order: (a) reduction of cash payments; (b) reduction
of vesting acceleration of equity awards; and (c) reduction of other benefits paid or provided to the Grantee. In the event
that acceleration of vesting of equity awards is to be reduced, such acceleration of vesting will be cancelled in the reverse order
of the date of grant for the Grantee’s equity awards. If two or more equity awards are granted on the same date, each award
will be reduced on a pro-rata basis. In no event will the Grantee exercise any discretion with respect to the ordering of
any reductions of payments or benefits under this Section 4.

B.                
Determination. Unless the Company and the Grantee otherwise agree in
writing, any determination required under this Section 4 shall be made in writing by the Company’s independent public
accountants or a national “Big Four” accounting firm selected by the Company (the “Accountants”),
whose determination shall be conclusive and binding upon the Grantee and the Company for all purposes. For purposes of making the
calculations required by this Section 4, the Accountants may make reasonable assumptions and approximations concerning applicable
taxes and may rely on reasonable, good faith interpretations concerning the application of Section 280G and 4999 of the Code.
The Company and the Grantee shall furnish to the Accountants such information and documents as the Accountants may reasonably request
in order to make a determination under this Section 4. The Company shall bear all costs the Accountants may reasonably incur
in connection with any calculations contemplated by this Section 4. 

5.                 
Restrictions on Transfer.

A.                
Investment Representations and Legend Requirements. The Grantee hereby
makes the investment representations listed on Exhibit A to the Company as of the date of this Agreement, and agrees that
such representations are incorporated into this Agreement by this reference, such that the Company may rely on them in issuing
the Shares. The Grantee understands and agrees that the Company shall cause the legends set forth below, or substantially equivalent
legends, to be placed upon any certificate(s) evidencing ownership of the Shares, together with any other legends that may be required
by the Company or by applicable state or federal securities laws including legends relating to the Company’s Voting Agreement
and/or Lock-up Agreement: 

THE SECURITIES
REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) AND MAY NOT
BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION
OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES
WITH THE ACT.

    	3

    	 

    

 

 

THE SECURITIES
REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND RIGHTS OF FORFEITURE HELD BY THE ISSUER OR
ITS ASSIGNEE(S) AS SET FORTH IN THE RESTRICTED SECURITIES AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SECURITIES,
A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS AND FORFEITURE RIGHTS ARE BINDING
ON TRANSFEREES OF THESE SECURITIES.

B.                
Stop-Transfer Notices. The Grantee agrees that to ensure compliance with the
restrictions referred to herein, the Company may issue appropriate “stop transfer” instructions to its transfer agent,
if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its
own records.

C.                
Refusal to Transfer. The Company shall not be required (i) to transfer
on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement, the
Company’s Voting Agreement and Lock-up Agreement, if applicable or (ii) to treat as owner of such Shares or to accord
the right to vote or pay dividends or distributions to any grantee or other transferee to whom such Shares shall have been transferred
in violation of any of the provisions of this Agreement, the Company’s Voting Agreement and Lock-up Agreement, if applicable.

D.                
Unvested Shares. No Unvested Shares nor any beneficial interest in any of such
Shares, shall be sold, gifted, transferred, encumbered or otherwise disposed of in any way (whether by operation of law or otherwise)
by the Grantee.

E.                 
Vested Shares. No Vested Shares purchased pursuant to this Agreement, nor any
beneficial interest in such Vested Shares, shall be sold, transferred, encumbered or otherwise disposed of in any way (whether
by operation of law or otherwise) by the Grantee or any subsequent transferee, except in compliance with the terms and conditions
of this Agreement, the Company’s Voting Agreement and Lock-up Agreement, if applicable.

6.                 
Tax Consequences. The Grantee has reviewed with the Grantee’s own tax advisors
the federal, state, local and foreign tax consequences of ownership of the Shares and the transactions contemplated by this Agreement.
The Grantee is relying solely on such advisors and not on any statements or representations of the Company or any of its agents.
The Grantee understands that the Grantee (and not the Company) shall be responsible for any tax liability that may arise as a result
of the transactions contemplated by this Agreement. The Grantee understands that Section 83 of the Code taxes as ordinary
income the difference between the purchase price of the Shares and the fair market value of the Shares as of the date the Shares
vest and any restrictions on the Shares lapse. The Grantee understands that the Grantee may elect to be taxed at the time the Shares
are granted rather than when and as the Shares vest by filing an election under Section 83(b) of the Code with the IRS within 30
days from the date of grant. The form for making this section 83(b) election is
attached to this agreement as Exhibit B and the Grantee (and not the Company or any of its agents) shall be solely
responsible for appropriately filing such form, even if the Grantee requests the company or its agents to make this filing on THE
Grantee’s behalf.

    	4

    	 

    

7.                 
General Provisions.

A.                
Governing Law. This Agreement shall be governed
by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under
applicable principles of conflicts of law.  

B.                
Entire Agreement. This Agreement (including any Exhibits hereto) constitutes
the full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written
or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled, including, but not
limited to, any representations made during any interviews, relocation discussions or negotiations whether written or oral.

C.                
Notices. All notices and other communications given or made pursuant to this
Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or: (i) personal delivery
to the party to be notified; (ii) when sent, if sent by electronic mail or facsimile during the recipient’s normal business
hours, and if not sent during normal business hours, then on the recipient’s next business day; (iii) five (5) days after
having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one (1) business day after
the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery, with
written verification of receipt. All communications shall be sent to the Grantee at its address as set forth on the signature page
hereto or which is on record with the Company, or to the principal office of the Company and to the attention of the Chief Financial
Officer, in the case of the Company, or to such email address, facsimile number, or address as subsequently modified by written
notice given in accordance with this Section 7(C). 

D.                
Assignment; Transfers. Except as set forth in this Agreement, this Agreement,
and any and all rights, duties and obligations hereunder, shall not be assigned, transferred, delegated or sublicensed by the Grantee
without the prior written consent of the Company. Any attempt by the Grantee without such consent to assign, transfer, delegate
or sublicense any rights, duties or obligations that arise under this Agreement shall be void. Except as set forth in this Agreement,
any transfers in violation of any restriction upon transfer contained in any section of this Agreement shall be void, unless such
restriction is waived in accordance with the terms of this Agreement.

E.                 
Delays or Omissions. No delay or omission to exercise any right, power, or remedy
accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any
such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or acquiescence
to any such breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach
or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All remedies, whether under this
Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative. 

F.                 
Grantee Investment Representations and Further Documents. The Grantee agrees
upon request to execute any further documents or instruments necessary or reasonably desirable in the view of the Company to carry
out the purposes or intent of this Agreement, including (but not limited to) the applicable exhibits and attachments to this
Agreement.

    	5

    	 

    

 

 

G.                
Severability. In case any one or more of the provisions contained in this Agreement
is for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability
shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be reformed
and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law. 

H.                
Rights as Shareholder/Member. Subject to the terms and conditions of this Agreement,
the Grantee shall have all of the rights of a member or shareholder of the Company with respect to the Vested Shares and Unvested
Shares, from and after the date of this Agreement (including the applicable exhibits and attachments to this Agreement) to the
Company, and until such time as the Grantee disposes of the Shares in accordance with this Agreement. Upon such transfer, the Grantee
shall have no further rights as a holder of the Shares so purchased except (in the case of a transfer to the Company) the right
to receive payment for the Shares so purchased in accordance with the provisions of this Agreement, and the Grantee shall forthwith
cause the certificate(s) evidencing the Shares so purchased to be surrendered to the Company for transfer or cancellation.

I.                   
Adjustment for Securities Split. All references to the number of Shares
in this Agreement shall be adjusted to reflect any split, dividend or other change in the Shares which may be made after the date
of this Agreement.

J.                  
Service at Will. THE GRANTEE ACKNOWLEDGES AND AGREES THAT THE VESTING OF THE
SHARES PURSUANT TO THIS AGREEMENT IS EARNED ONLY BY CONTINUING SERVICE OF THE GRANTEE AS A SERVICE PROVIDER AT WILL AND SUBJECT
TO ACCELERATION AS PROVIDED IN SECTION 3 HEREOF (AND NOT THROUGH THE ACT OF BEING HIRED OR PURCHASING SHARES HEREUNDER). THE GRANTEE
FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH
HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT OF THE GRANTEE AS A SERVICE PROVIDER FOR THE VESTING
PERIOD, OR FOR ANY PERIOD AT ALL, AND SHALL NOT INTERFERE WITH THE GRANTEE’S RIGHT OR THE COMPANY’S RIGHT TO TERMINATE
THE GRANTEE’S RELATIONSHIP WITH THE COMPANY AT ANY TIME, WITH OR WITHOUT CAUSE OR NOTICE.

K.                
Dispute Resolution.

(1)              
Forum and Venue. Except as otherwise specifically provided in this Agreement, any controversy or claim arising out
of or relating to this Agreement shall be resolved exclusively through binding arbitration in accordance with the rules of the
American Arbitration Association, and judgment upon an award arising in connection therewith may be entered in any court of competent
jurisdiction. Any arbitration, mediation, court action, or other adjudicative proceeding arising out of or relating to this Agreement
shall be held in Denver, Colorado, or, if such proceeding cannot be lawfully held in such location, as near thereto as applicable
law permits.

    	6

    	 

    

 

 

(2)              
Fees and Costs. The prevailing party or parties in any arbitration, mediation, court action, or other adjudicative
proceeding arising out of or relating to this Agreement shall be reimbursed by the party or parties who do not prevail for their
reasonable attorneys, accountants and experts fees and related expenses (including reasonable charges for in-house legal counsel
and related personnel) and for the costs of such proceeding. In the event that two or more parties are deemed liable for a specific
amount payable or reimbursable under this Section 7(K), such parties shall be jointly and severally liable therefore.

(3)              
Special Acknowledgment. EACH GRANTEE ACKNOWLEDGES AND AGREES THAT: (i) SUCH GRANTEE IS EXECUTING THIS AGREEMENT
VOLUNTARILY AND WITHOUT ANY DURESS OR UNDUE INFLUENCE BY THE COMPANY OR ANYONE ELSE; (ii) SUCH GRANTEE HAS CAREFULLY READ
AND FULLY UNDERSTANDS THIS AGREEMENT; (iii) SUCH GRANTEE IS WAIVING ANY RIGHT TO A JURY TRIAL; AND (iv) THIS AGREEMENT
IS INTENDED TO BE STRICTLY ENFORCEABLE. EACH GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT IT HAS BEEN PROVIDED AN OPPORTUNITY TO
SEEK THE ADVICE OF AN ATTORNEY OF ITS CHOICE BEFORE SIGNING THIS AGREEMENT.

L.                 
Reliance on Counsel and Advisors. The Grantee acknowledges that he or
she has had the opportunity to review this Agreement, including all attachments hereto, and the transactions contemplated by this
Agreement with his or her own legal counsel, tax advisors and other advisors. The Grantee is relying solely on his or her own counsel
and advisors and not on any statements or representations of the Company or its agents for legal or other advice with respect to
this investment or the transactions contemplated by this Agreement.

M.               
Counterparts. This Agreement may be executed in two or more counterparts, each
of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may
be delivered via facsimile, electronic mail (including .pdf) or other transmission method and any counterpart so delivered shall
be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

[Remainder of Page
Intentionally Left Blank]

 

    	7

    	 

    

The parties represent
that they have read this Agreement in its entirety, have had an opportunity to obtain the advice of counsel prior to executing
this Agreement and fully understand this Restricted Securities Award Agreement.

Grantee:

Gregory C. Venn

/s/ Gregory C. Venn

Signature 

Gregory C. Venn

Print Name

Company:

NEXCORE HEALTHCARE CAPITAL CORP

 

/s/ Robert E. Lawless

Signature

 

/s/ Robert E. Lawless

Print Name

 

Chief Financial Officer

Print Title

 

 

    	 

    	 

    

EXHIBIT A

INVESTMENT REPRESENTATION
STATEMENT

GRANTEE:Gregory C. Venn

COMPANY:NexCore Healthcare Capital
Corp

SECURITY:Restricted Securities

AMOUNT:174,675 Shares

DATE:December 16, 2013

In connection with
the purchase of the above-listed Shares, I, the undersigned Grantee, represent to the Company as follows:

1.                 
The Company may rely on these representations. I understand that the Company’s
sale of the Shares to me has not been registered under the Securities Act of 1933, as amended (the “Securities Act”),
because the Company believes, relying in part on my representations in this document, that an exemption from such registration
requirement is available for such sale. I understand that the availability of this exemption depends upon the representations I
am making to the Company in this document being true and correct. 

2.                 
I am purchasing for investment. I am purchasing the Shares solely for investment
purposes, and not for further distribution. My entire legal and beneficial ownership interest in the Shares is being purchased
and shall be held solely for my account, except to the extent I intend to hold the Shares jointly with my spouse. I am not a party
to, and do not presently intend to enter into, any contract or other arrangement with any other person or entity involving the
resale, transfer, grant of participation with respect to or other distribution of any of the Shares. My investment intent is not
to hold the Shares for the minimum capital gains period specified under any applicable tax law, for a deferred sale, for a specified
increase or decrease in the market price of the Shares, or for any other fixed period in the future. 

3.                 
I can protect my own interests. I can properly evaluate the merits and risks
of an investment in the Shares and can protect my own interests in this regard, whether by reason of my own business and financial
expertise, the business and financial expertise of certain professional advisors unaffiliated with the Company with whom I have
consulted, or my preexisting business or personal relationship with the Company or any of its officers, directors or controlling
persons.

4.                 
I am informed about the Company. I am sufficiently aware of the Company’s
business affairs and financial condition to reach an informed and knowledgeable decision to acquire the Shares. I have had opportunity
to discuss the plans, operations and financial condition of the Company with its officers, directors or controlling persons, and
have received all information I deem appropriate for assessing the risk of an investment in the Shares.

5.                 
I recognize my economic risk. I realize that the purchase of the Shares involves
a high degree of risk, and that the Company’s future prospects are uncertain. I am able to hold the Shares indefinitely if
required, and am able to bear the loss of my entire investment in the Shares.

    	 

    	 

    

6.                 
I know that the Shares are restricted securities. I understand that the Shares
are “restricted securities” in that the Company’s sale of the Shares to me has not been registered under the
Securities Act in reliance upon an exemption for non-public offerings. In this regard, I also understand and agree that:

A.                
I must hold the Shares indefinitely, unless any subsequent proposed resale by me is registered
under the Securities Act, or unless an exemption from registration is otherwise available (such as Rule 144);

B.                
the Company is under no obligation to register any subsequent proposed resale of the shares
by me; and

C.                
the certificate evidencing the Shares will be imprinted with a legend which prohibits the
transfer of the Shares unless such transfer is registered or such registration is not required in the opinion of counsel for the
Company.

7.                 
I am familiar with Rule 144. I am familiar with Rule 144 adopted under
the Securities Act, which in some circumstances permits limited public resales of “restricted securities” like the
Shares acquired from an issuer in a non-public offering. I understand that my ability to sell the Shares under Rule 144 in the
future is uncertain, and may depend upon, among other things: (i) the availability of certain current public information about
the Company; (ii) the resale occurring more than a specified period after my purchase and full payment (within the meaning
of Rule 144) for the Shares; and (iii) if I am an affiliate of the Company (A) the sale being made in an unsolicited
“broker’s transaction”, transactions directly with a market maker or riskless principal transactions, as those
terms are defined under the Securities Exchange Act of 1934, as amended, (B) the amount of Shares being sold during any three-month
period not exceeding the specified limitations stated in Rule 144, and (C) timely filing of a notice of proposed sale on
Form 144, if applicable. 

8.                 
I know that Rule 144 may never be available. I understand that the requirements
of Rule 144 may never be met, and that the Shares may never be saleable under the rule. I further understand that at the time
I wish to sell the Shares, there may be no public market for the Company’s Shares upon which to make such a sale, or the
current public information requirements of Rule 144 may not be satisfied, either of which may preclude me from selling the
Shares under Rule 144 even if the relevant holding period had been satisfied.

9.                 
I know that I am subject to further restrictions on resale. I understand that
in the event Rule 144 is not available to me, any future proposed sale of any of the Shares by me will not be possible without
prior registration under the Securities Act, compliance with some other registration exemption (which may or may not be available),
or each of the following: (i) my written notice to the Company containing detailed information regarding the proposed sale,
(ii) my providing an opinion of my counsel to the effect that such sale will not require registration, and (iii) the Company
notifying me in writing that its counsel concurs in such opinion. I understand that neither the Company nor its counsel is obligated
to provide me with any such opinion. I understand that although Rule 144 is not exclusive, the Staff of the SEC has stated
that persons proposing to sell private placement securities other than in a registered offering or pursuant to Rule 144 will
have a substantial burden of proof in establishing that an exemption from registration is available for such offers or sales, and
that such persons and their respective brokers who participate in such transactions do so at their own risk.

    	 

    	 

    

 

 

10.             
I know that I may have tax liability due to the uncertain value of the Shares.
I understand that the Over-the-Counter (OTC) price on the Grant Date of the Shares represents a fair appraisal of their worth,
but that it remains possible that, with the benefit of hindsight, the Internal Revenue Service may successfully assert that the
value of the Shares on the date of my purchase is substantially greater than the OTC price on the Grant Date. I understand that
any additional value ascribed to the Shares by such an IRS determination will constitute ordinary income to me as of the purchase
date, and that any additional taxes and interest due as a result will be my sole responsibility payable only by me, and that the
Company need not and will not reimburse me for that tax liability.

11.             
Residence. The address of my principal residence is on record with the Company.

By signing below,
I acknowledge my agreement with each of the statements contained in this Investment Representation Statement as of the date first
set forth above, and my intent for the Company to rely on such statements in issuing the Shares to me.

 

 

/s/ Gregory C. Venn

Grantee’s Signature

 

Gregory C. Venn

Print Name

 

 

    	 

    	 

    

IF YOU WISH TO MAKE A SECTION 83(B)
ELECTION, THE FILING OF SUCH ELECTION IS YOUR RESPONSIBILITY.

 

 

the
form for making this section 83(B) election is attached to this agreement as Exhibit B. 

 

YOU
MUST FILE THIS FORM WITHIN 30 DAYS OF THE DATE OF AWARD OF THE SHARES.

 

YOU
(and not the Company or any of its agents) shall be solely responsible for filing such form WITH THE IRS, even if YOU request
the company or its agents to make this filing on YOUR behalf and even if the company or its agents have previously made this filing
on YOUR Behalf.

 

 

 

The
election should be filed by mailing a signed election form by certified mail, return receipt requested to the IRS Service Center
where you file your tax returns. See <www.irs.gov>

    	 

    	 

    

EXHIBIT B

 

ELECTION UNDER SECTION 83(b) OF THE

INTERNAL REVENUE CODE OF 1986, AS AMENDED

 

The undersigned
taxpayer hereby elects, pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in his or her
gross income the amount of any compensation taxable to him or her in connection with his or her receipt of the property described
below:

 

1.                 
The name, address and taxpayer identification number of the undersigned are as follows:

NAME OF TAXPAYER: Gregory C. Venn

TAXPAYER’S ADDRESS:

 

TAXPAYER ID #: 

2.                 
The property with respect to which the election is made is described as follows: 174,675 shares
of common stock of NexCore Healthcare Capital Corp (the “Company”) and 174,675 Class B Units of NexCore
Real Estate LLC (the “Shares”).

3.                 
The date on which the property was transferred is: December 16, 2013.

4.                 
The taxable year for which the election is made is: 2013.

5.                 
The property is subject to a two-year vesting schedule. In addition, the Shares are subject
to forfeiture upon the occurrence of certain events. This right lapses with regard to all of the Shares upon the occurrence of
certain events.

6.                 
The fair market value at the time of transfer, determined without regard to any restriction
other than a restriction which by its terms will never lapse, of such property is: $ 78,604.

7.                 
The amount, if any, paid for such property: $0.

 

The undersigned
has submitted a copy of this statement to the person for whom the services were performed in connection with the undersigned’s
receipt of the above-described property. The transferee of such property is the person performing the services in connection with
the transfer of said property.

 

The undersigned
understand(s) that the foregoing election may not be revoked except with the consent of the Commissioner.

 

 

Dated: January 10, 2014

TaxpayerVOTING AGREEMENT 

 

This Voting Agreement (this
“Agreement”) is entered into this 15th day of December, 2013 by and among the undersigned shareholders of NexCore
Healthcare Capital Corp, a Delaware corporation (“NexCore Healthcare”), and the members of NexCore Real Estate LLC,
a Delaware limited liability company (“NexCore Real Estate”), (individually an “Investor” and collectively
the “Investors”) and Gregory C. Venn and Peter K. Kloepfer (the “NexCore Members”). For the
avoidance of doubt, Mssrs. Venn and Kloepfer are also Investors hereunder, and will execute this Agreement in both capacities.

 

RECITALS

 

WHEREAS, each Investor
is a beneficiary of a voting trust (the “Voting Trust”) formed pursuant to that certain Voting Trust Agreement
dated September 29, 2010;

 

 

 

WHEREAS, the Investors
and the NexCore Members desire to replace the existing Voting Trust with this Agreement in order to reduce tax preparation and
advisory costs and to simplify and enhance the timeliness of Investor reporting.

 

 

AGREEMENT

 

NOW, THEREFORE, in consideration
of the mutual promises and covenants contained herein, and for other valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto agree as follows:

 

1.Securities
Subject to this Agreement. All shares of NexCore Healthcare common stock and all class B common units of NexCore Real Estate
(collectively the “Securities”) owned by an Investor as of the date of this Agreement will be subject to the terms
and conditions of this Agreement. Additionally, any Securities issued pursuant to or through the receipt of any dividends or distributions
on Securities covered by this Agreement, or grants or exercise of options, warrants, convertible securities or other rights that
have been or are granted to any Investor or through any Securities split, combination or other recapitalization prior to the Termination
Date shall be subject to the terms and conditions of this Agreement. Notwithstanding the foregoing, any Securities that were or
are acquired by an Investor in the open market or that were released subject to Section 2 below shall not be subject to the terms
and conditions of this Agreement.

    	1

    	 

    

 

2.Permitted
Transfers. Subject to the terms of this Agreement, each Investor may, upon notice to the NexCore Members, transfer up to twenty-five
percent (25%) of their Securities, as measured on the date of this Agreement, to a Permitted Transferee, and any such transferred
Securities shall be released from the terms of this Agreement (subject to any terms and limitations within the NexCore Healthcare
bylaws and the NexCore Real Estate operating agreement as well as any applicable securities laws). “Permitted Transferee”
shall mean (i) an Immediate Family Member (defined as a spouse, lineal descendant, adopted child and his or her lineal descendants,
father, mother, brother or sister of such Investor), (ii) trusts for the benefit of the Investor and/or one or more of the Investor’s
Immediate Family Member(s), and (iii) corporations, limited liability companies, or partnerships in which the Investor or the Investor’s
Immediate Family Member(s) own a majority of the capital and voting interest. Further, each Investor may, upon notice to the NexCore
Members, transfer any or all of their Securities, as measured on the date of this Agreement, to charitable organizations or foundations.

3.Release
of Units Subject to the Voting Trust. The trustees of the Voting Trust now hereby release all Securities subject to the Voting
Trust with respect to the undersigned parties, as the beneficiaries of the Voting Trust. The Voting Trust shall terminate with
respect to the undersigned Investors but shall continue with respect to any beneficiaries of the Voting Trust who do not become
parties to this Agreement.

4.Irrevocable
Proxy and Power of Attorney.

(a)Each
Investor hereby constitutes and appoints as the proxies of such Investor and hereby grants a power of attorney to each NexCore
Member with full power of substitution, with respect to all matters submitted to a vote of the Investors, including without limitation,
election of persons as members of the Company’s Board of Directors as applicable. Each of the proxy and power of attorney
granted pursuant to the immediately preceding sentence is given in consideration of the agreements and covenants of the Investors
in connection with the transactions contemplated by this Agreement and, as such, each is coupled with an interest and shall be
irrevocable unless and until this Agreement terminates or expires pursuant to Section 7 hereof. Each Investor hereby revokes any
and all previous proxies or powers of attorney with respect to its Securities and shall not hereafter, unless and until this Agreement
terminates, grant or purport to grant any other proxy or power of attorney with respect to any of such Securities, deposit any
of the Securities into a voting trust or enter into any agreement (other than this Agreement), arrangement or understanding with
any person, directly or indirectly, to vote, grant any proxy or give instructions with respect to the voting of any of the Securities,
in each case, with respect to any of the matters set forth herein.

(b)Each
Investor hereby makes, constitutes and appoints each of the NexCore Members (each an “Attorney”) the true and
lawful agent and attorney-in-fact, with full power of substitution and resubstitution, of the Investor, for and in Investor's name,
place and stead, in any and all capacities, to do all or any of the following acts, matters and things:

    	2

    	 

    

(i)to sign on behalf of the
Investor statements on Schedule 13D or 13G or Forms 3, 4 and 5, or amendments thereto pursuant to Section 13(d) or Section 16 under
the Securities Exchange Act of 1934;

 

(ii)to do all such other acts
and things as, in such Attorney's discretion, he or she deems appropriate or desirable for the purpose of filing such statements
on Schedule 13D or 13G or Forms 3, 4 and 5, or amendments thereto; and

 

(iii)to appoint in writing
one or more substitutes who shall have the power to act on behalf of the Investor as if that substitute or those substitutes shall
have been originally appointed Attorney (s) by the power of attorney provided by this Section 4(b) and/or to revoke any such appointment
at any time without assigning any reason therefor.

 

The Investor hereby ratifies
and confirms all that said Attorneys or any substitute or substitutes may lawfully do or cause to be done by virtue hereof. The
power of attorney provided by this Section 4(b) shall remain in full force and effect until the Investor is no longer required
to file Forms 3, 4 and 5 or to file reports under Section 13(d) of the Securities Exchange Act of 1934 with respect to the Investor's
holdings of and transactions in Securities issued by the Company.

 

5.Schedule 13D Group Disclosure.
Each Member acknowledges that entry into this Agreement may result in the Investors collectively being deemed a “group”
for purposes of Regulation 13D of the Securities and Exchange Commission (“SEC”). Each Investor further acknowledges
that, as a member of the group, the Investor will be required to join with the other Investors in executing and filing documents
with the SEC that will disclose information about the Investor pertaining to its holdings in the Company. The power of attorney
provided in Section 4(b) hereof authorizes the Attorneys to sign on behalf of each Investor and file with the SEC any filings necessary
under Sections 13 or 16 of the Securities Exchange Act of 1934.

 

6.Reorganization
or Recapitalization of the Company. Except as otherwise provided in Section 6, in the event the Company (meaning NexCore Healthcare
and NexCore Real Estate individually or collectively for purposes of this Section 6) is merged into or consolidated with another
entity, or all or substantially all of the assets of the Company are transferred to another entity pursuant to a plan requiring
the Company’s assets to be distributed in liquidation, or all the Securities of the Company are to be exchanged in connection
with a reorganization or recapitalization of the Company, then in connection with such transaction or series of transactions the
term “the Company” for all purposes of this Agreement shall be taken to include any such successor entity.

    	3

    	 

    

 

7.Term.

 

(a) This
Agreement shall take effect on the date first above written and continue in effect until September 29, 2015 (subject to extension
as hereinafter set forth) but shall terminate at any time upon the happening of any of the following events: (i) the execution
and acknowledgement by the NexCore Members of a notice terminating this Agreement, a copy of which shall be sent promptly to each
Investor; or (ii) the execution by holders representing 90% or more of the Securities subject to this Agreement of a consent to
the termination of this Agreement, delivered promptly to the NexCore Members (the “Termination Date”).

 

(b) At any
time, the holders representing 90% or more of the Securities subject to this Agreement may, by agreement in writing and with the
written consent of the NexCore Members, extend the duration of this Agreement for one or more additional periods, with notice of
any such extension delivered promptly to the Investors.

 

8.Duties of NexCore
Members. The parties recognize that the NexCore Members will be required to balance various conflicting interests, including
personal interests of the NexCore Members. The NexCore Members shall not be personally responsible, nor shall any vote, action
or inaction of the NexCore Members be subject to challenge, if the NexCore Members action or failure to act was in good faith,
without gross negligence, and in a manner that the NexCore Members believed to be in the best interest of the Company.  In
so voting, the NexCore Members may consider the interests of the Company’s employees, suppliers, customers and creditors
and the communities in which the Company’s activities are located.  The NexCore Members shall not be subject to
any duties or obligations except as expressly stated herein.  The Investors, jointly and severally, agree to indemnify
and hold the NexCore Members harmless from any and all liability for actions or inaction taken in accordance with the foregoing
standard of conduct.

 

9.Remedies Cumulative.
All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

 

10.Severability.
The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement.

 

11.Governing Law.
This Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware (without giving
effect to the conflicts of law provisions thereof).

 

12.Notices.
All notices to be given or otherwise made to any party to this Agreement shall be in writing and shall be hand delivered, sent
by facsimile, or mailed, postage prepaid to any Investor at the address reflected on the records of the Company until such time
as the Company receives notice of a change.

    	4

    	 

    

 

Each such notice, report,
or other communication shall, for all purposes hereof, be treated as effective or having been given when delivered if delivered
personally or, if sent by mail, at the earlier of its receipt or 72 hours after the same has been deposited in a regularly maintained
receptacle for the deposit of the United States mail, addressed and mailed as aforesaid, or, if sent by facsimile with written
confirmation, at the earlier of (i) 24 hours after confirmation of transmission by the sending facsimile machine or (ii) delivery
of written confirmation.

 

13.Complete Agreement.
This Agreement constitutes the entire agreement and understanding of the parties hereto with respect to the subject matter hereof
and supersedes all prior agreements and understandings relating to such subject matter, whether oral or written.

 

14.Modification
or Amendment. Neither this Agreement nor any provision hereof can be modified or changed, except by an instrument in writing,
signed by majority-in-interest of the Investors.

 

15.Pronouns.
Whenever the context may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine, or neuter
forms, and the singular form of nouns and pronouns shall include the plural, and vice versa.

 

16.Counterparts;
Facsimile Signatures. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an
original, and all of which together shall constitute one and the same document. This Agreement may be executed by electronic or
facsimile signatures.

 

17.Section Headings.
The section headings are for the convenience of the parties and in no way alter, modify, amend, limit, or restrict the contractual
obligations of the parties.

 

[Signature pages follow]

 

    	5

    	 

    

 

IN WITNESS WHEREOF, the
parties hereto have caused this Voting Agreement to be executed as of the date first above written.

 

NEXCORE MEMBERS

 

By: /s/ Gregory
C Venn

Name: Gregory C. Venn

 

By: /s/ Peter
K. Kloepfer 

Name: Peter K. Kloepfer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 

    	 

    

IN WITNESS WHEREOF, the
parties hereto have caused this Voting Agreement to be executed as of the date first above written.

 

INVESTOR

 

 

________________________________

Name:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}]]